IMI at BIO 2016

Start Date 06/06/2016 End Date 09/06/2016

IMI took part in the 2016 edition of the BIO International Convention in San Francisco, US on 6-9 June 2016.

Workshop on novel anti-infectives

IMI teamed up with its ENABLE project and the Wellcome Trust-funded Community For Open Antimicrobial Drug Discovery (CO-ADD) to organise a workshop dedicated to novel antibiotics and antimicrobial resistance (AMR) innovation. The workshop brought together around 200 people from the scientific, finance and business communities to network around promising antibiotic products and technologies. Specifically, it showcased global research programmes supporting the development of novel anti-infectives as well as 10 innovative small companies from around the world that are pioneers in the development of new antibiotics. A panel of judges picked Bioversys as the best presentation, while EpiBiome won the public vote.

Programme presentations

Company presentations

IMI session ‘Revolutionizing Clinical Trials for Alzheimer’s: An International Perspective on Adaptive Clinical Trials’

Over 150 people attended a session organised by IMI in the brain health track of the BIO educational programme. Despite decades of research, there is still neither treatment nor cure for Alzheimer’s disease and success in clinical trials remains elusive. Pioneering projects on both sides of the Atlantic are working together to turn this situation around by running adaptive clinical trials – a first in Alzheimer’s research. In this session, leading dementia experts, including from IMI's EPAD project, shared their experiences and discussed how best to overcome the challenges to delivering successful clinical trials for much-needed Alzheimer’s treatments.


Session ‘Bridging the Gap: Alignment of Global Antibiotic R&D Partnerships’

IMI Executive Director Pierre Meulien was a speaker in this session on the critical need for global alignment in the anti-infective development chain.

IMI at the exhibition

IMI was also present at the European Commission’s booth at the BIO Exhibition.

About BIO

The BIO International Convention (BIO) attracts over 15 000 biotechnology and pharma leaders who come together for a week of intensive networking and partnering opportunities. The event features a strong educational programme as well as an expansive exhibition floor.